Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to $130357.0.

  • BioScience Health Innovations' Other Operating Expenses rose 46067.53% to $130357.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $271721.0, marking a year-over-year increase of 38049.69%. This contributed to the annual value of $75478.0 for FY2024, which is 15456.32% up from last year.
  • According to the latest figures from Q3 2025, BioScience Health Innovations' Other Operating Expenses is $130357.0, which was up 46067.53% from $76700.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Other Operating Expenses high stood at $130357.0 for Q3 2025, and its period low was $9850.0 during Q1 2024.
  • Moreover, its 3-year median value for Other Operating Expenses was $28878.0 (2024), whereas its average is $46455.2.
  • In the last 5 years, BioScience Health Innovations' Other Operating Expenses tumbled by 8903.44% in 2024 and then soared by 46814.81% in 2025.
  • Over the past 3 years, BioScience Health Innovations' Other Operating Expenses (Quarter) stood at $9950.0 in 2023, then surged by 190.23% to $28878.0 in 2024, then surged by 351.41% to $130357.0 in 2025.
  • Its Other Operating Expenses stands at $130357.0 for Q3 2025, versus $76700.0 for Q2 2025 and $35786.0 for Q1 2025.